why choose us

First received: January 29, 2023

Clinical Trial: Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Advanced Solid Tumors

Study Type: Interventional


Official Title: Phase I Clinical Trial of Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors

Brief Summary: This is an open, multi-dose administration dose exploratory clinical phase I study to evaluate the safety, tolerability, and PK characteristics of HX009 injection in patients with advanced solid tumors and to initially measure its antitumor efficacy.

Read more